Aristides Capital LLC Ocular Therapeutix, Inc Transaction History

Aristides Capital LLC

  • $219 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$2.08 - $4.52 $104,470 - $227,021
50,226 New
50,226 $224,000
Q1 2023

May 12, 2023
BUY
$2.79 - $6.27 $97,650 - $219,449
35,000 New
35,000 $184,000
Q1 2022

May 16, 2022
SELL
$4.83 - $7.35 $206,472 - $314,197
-42,748 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $263,327 - $515,968
42,748 New
42,748 $298,000

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Aristides Capital LLC Portfolio

Follow Aristides Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristides Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email